Worldwide neuromodulation device market could hit $6.8B in 4 years

01/15/2013 | MedCityNews.com

A MarketsandMarkets report forecasts that by 2017, the worldwide neuromodulation device market will be valued at $6.8 billion, making it the fastest growing segment of the medtech industry. This growth will be fueled in part by the increased demand for minimally invasive ways to treat epilepsy, stroke, chronic pain and other conditions.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA